MétaCan
Menu
Back to cohort
Record W2471505848 · doi:10.1177/135965350400900602

Alternation of Antiretroviral Drug Regimens for HIV Infection. Efficacy, Safety and Tolerability at Week 96 of the Swatch Study

2004· article· en· W2471505848 on OpenAlexaff
Eugènia Negredo, Roger Paredes, Joaquim Peraire, Enric Pedrol, Hélène C. F. Côté, Sílvia Gel, Carmina R. Fumaz, Lı́dia Ruiz, Vicente Abril, Eduardo Rodríguez de Castro, Claudia Ochoa, Javier Martínez‐Picado, Joan Montaner, Celestino Rey‐Joly, Bonaventura Clotet, B. Clotet, CR Fumaz, JA Muñoz‐Moreno, Anna Bonjoch, J. M. Martínez, Jordi Puig, ER Arisa, Albert Tuldrà, A. Jou, C. Tural, G. Sirera, Joan Romeu, Carlos Zala, Pedro Cahn, Oberto Torres, Peré Domingo, Josep Vilaró, Josep M. Llibre, Francesc Vidal, Cristóbal Richart, Consuelo Viladés, Lainie P. Martin, R Rodríguez, Rosario Mata, Pompeyo Viciana, Rafael Rubio, Miguel Torralba, M. Cervantes, JM Gatell, Montse Loncà, Isaac Cieza Ruiz, Carlos Azuaje

Bibliographic record

VenueAntiviral Therapy · 2004
Typearticle
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsAIDS Vancouver
FundersNational Institute of Allergy and Infectious Diseases
KeywordsTolerabilityLamivudineRegimenDidanosineInternal medicineEfavirenzNelfinavirMedicineStavudineZidovudineGastroenterologyAdverse effectViral loadPharmacologyImmunologyHuman immunodeficiency virus (HIV)Viral diseaseAntiretroviral therapyVirus

Abstract

fetched live from OpenAlex

INTRODUCTION: Alternation of antiretroviral drug regimens has been proposed as a novel treatment strategy for HIV infection. However, some concerns persist regarding antiviral efficacy, adherence, toxicity and resistance evolution in the long term. METHODS: A total of 161 antiretroviral-naive HIV-1-infected patients were randomized to receive stavudine/didanosine/efavirenz (group A) or zidovudine/lamivudine/ nelfinavir (group B) or to alternate between the two regimens every 3 months starting with regimen A (group C). Antiviral efficacy, adherence, safety and tolerability were analysed every 12 weeks. RESULTS: After 96 weeks, time to virological failure was significantly delayed in the alternating regimen compared with the standards of care regimens. Virological suppression was seen in 46%, 48% and 58% of patients in groups A, B and C, respectively, in the intention-to-treat analysis and in 75%, 76% and 97% in the on-treatment analysis (A vs C: P=0.014; B vs C: P=0.016; A vs B: P=0.849). At the end of the study, 94% of patients in group A and 92% in groups B and C reported an adherence greater than 95%. Alternating therapy was associated with a similar impact on CD4+ counts in comparison with the standards of care regimens, as well as a lower mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio decrease in the mitochondrial substudy performed on 37 patients. The frequency and intensity of adverse events in the alternating group decreased during subsequent cycles. DISCUSSION: Our results favour the hypothesis that proactive therapy switching may delay the accumulation of resistance mutations. Moreover, the alternating regimen was well tolerated and adherence remained comparably high in all treatment groups. The lower mtDNA/nDNA ratio decrease observed in this group may imply a lower impact on mitochondrial toxicity than in standard regimens.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.099
Threshold uncertainty score0.363

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.020
GPT teacher head0.283
Teacher spread0.264 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations13
Published2004
Admission routes1
Has abstractyes

Explore more

Same venueAntiviral TherapySame topicHIV/AIDS drug development and treatmentFrench-language works237,207